Cargando…
Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems
Olfactory receptors (ORs) account for 49% of all G protein-coupled receptors (GPCRs), which are important targets for drug discovery, and hence ORs may also be potential drug targets. Various ORs are expressed in breast cancer cells; however, most of them are orphan receptors, and thus, their functi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156394/ https://www.ncbi.nlm.nih.gov/pubmed/34065710 http://dx.doi.org/10.3390/s21103468 |
_version_ | 1783699435010654208 |
---|---|
author | Choi, Yae Rim Shim, Jaewon Park, Jae-Ho Kim, Young-Suk Kim, Min Jung |
author_facet | Choi, Yae Rim Shim, Jaewon Park, Jae-Ho Kim, Young-Suk Kim, Min Jung |
author_sort | Choi, Yae Rim |
collection | PubMed |
description | Olfactory receptors (ORs) account for 49% of all G protein-coupled receptors (GPCRs), which are important targets for drug discovery, and hence ORs may also be potential drug targets. Various ORs are expressed in breast cancer cells; however, most of them are orphan receptors, and thus, their functions are unknown. Herein, we present an experimental strategy using a surface plasmon resonance (SPR) system and a cell-based assay that allowed the identification of orphan OR6M1 as a new anticancer target in the MCF-7 breast cancer cell line. After the construction of stable OR6M1-expressing cells, the SPR-based screening of 108 chemicals for ligand activity was performed against OR6M1-expressing whole cells (primary screening) or membrane fragments (secondary screening). As a result, anthraquinone (AQ) and rutin were discovered to be new OR6M1 ligands. Based on calcium imaging in OR6M1-expressing Hana3A cells, AQ and rutin were classified as an OR6M1 agonist and antagonist, respectively. Cell viability and live/dead assays showed that AQ induced the death of MCF-7 cells, which was inhibited by rutin. Therefore, OR6M1 may be considered an anticancer target, and AQ may be considered a chemotherapeutic agent. This combined method can be widely used to discover the ligands and functions of other orphan GPCRs. |
format | Online Article Text |
id | pubmed-8156394 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-81563942021-05-28 Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems Choi, Yae Rim Shim, Jaewon Park, Jae-Ho Kim, Young-Suk Kim, Min Jung Sensors (Basel) Article Olfactory receptors (ORs) account for 49% of all G protein-coupled receptors (GPCRs), which are important targets for drug discovery, and hence ORs may also be potential drug targets. Various ORs are expressed in breast cancer cells; however, most of them are orphan receptors, and thus, their functions are unknown. Herein, we present an experimental strategy using a surface plasmon resonance (SPR) system and a cell-based assay that allowed the identification of orphan OR6M1 as a new anticancer target in the MCF-7 breast cancer cell line. After the construction of stable OR6M1-expressing cells, the SPR-based screening of 108 chemicals for ligand activity was performed against OR6M1-expressing whole cells (primary screening) or membrane fragments (secondary screening). As a result, anthraquinone (AQ) and rutin were discovered to be new OR6M1 ligands. Based on calcium imaging in OR6M1-expressing Hana3A cells, AQ and rutin were classified as an OR6M1 agonist and antagonist, respectively. Cell viability and live/dead assays showed that AQ induced the death of MCF-7 cells, which was inhibited by rutin. Therefore, OR6M1 may be considered an anticancer target, and AQ may be considered a chemotherapeutic agent. This combined method can be widely used to discover the ligands and functions of other orphan GPCRs. MDPI 2021-05-16 /pmc/articles/PMC8156394/ /pubmed/34065710 http://dx.doi.org/10.3390/s21103468 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Choi, Yae Rim Shim, Jaewon Park, Jae-Ho Kim, Young-Suk Kim, Min Jung Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems |
title | Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems |
title_full | Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems |
title_fullStr | Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems |
title_full_unstemmed | Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems |
title_short | Discovery of Orphan Olfactory Receptor 6M1 as a New Anticancer Target in MCF-7 Cells by a Combination of Surface Plasmon Resonance-Based and Cell-Based Systems |
title_sort | discovery of orphan olfactory receptor 6m1 as a new anticancer target in mcf-7 cells by a combination of surface plasmon resonance-based and cell-based systems |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8156394/ https://www.ncbi.nlm.nih.gov/pubmed/34065710 http://dx.doi.org/10.3390/s21103468 |
work_keys_str_mv | AT choiyaerim discoveryoforphanolfactoryreceptor6m1asanewanticancertargetinmcf7cellsbyacombinationofsurfaceplasmonresonancebasedandcellbasedsystems AT shimjaewon discoveryoforphanolfactoryreceptor6m1asanewanticancertargetinmcf7cellsbyacombinationofsurfaceplasmonresonancebasedandcellbasedsystems AT parkjaeho discoveryoforphanolfactoryreceptor6m1asanewanticancertargetinmcf7cellsbyacombinationofsurfaceplasmonresonancebasedandcellbasedsystems AT kimyoungsuk discoveryoforphanolfactoryreceptor6m1asanewanticancertargetinmcf7cellsbyacombinationofsurfaceplasmonresonancebasedandcellbasedsystems AT kimminjung discoveryoforphanolfactoryreceptor6m1asanewanticancertargetinmcf7cellsbyacombinationofsurfaceplasmonresonancebasedandcellbasedsystems |